| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 03/03/2004 | EP1392664A1 Epothilone derivatives |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392657A2 Protease inhibitors |
| 03/03/2004 | EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016620A1 Polymorphic forms of dorzolamide chlorhydrate, production method thereof and pharmaceutical compositions containing same |
| 02/26/2004 | WO2004016604A2 Azabicyclic compounds are central nervous system active agents |
| 02/26/2004 | US20040039026 Macromolecules such as (12R,13S,15S)-cyclopropyl 5-methyl-pyridine epothilone A, used as tubulin polymerization promoters and for cytolysis cancer cells; antiproliferative agents |
| 02/26/2004 | US20040039009 Nitrogen compounds such as 5,6-dihydro-5,11-diketo-11H-indeno (1,2-c)isoquinoline, used as poly/ADP-ribose/ synthase inhibitors in cells, and for prophylaxis of reperfusion injuries, diabetes or inflammation |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038992 2-thio-(or oxy)-5-amino-1,3,4-thiadiazoles or oxadiazoles |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038971 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/26/2004 | US20040038970 Substituted with an imidazole ring; binds to somatostatin receptors and blocks Na channels; especially for treating arrhythmia and epilepsy |
| 02/26/2004 | US20040038965 Protease inhibitors |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | US20040038076 Poly (paraphenylenevinylene) derivatives and their use as electroluminescence materials |
| 02/26/2004 | CA2495589A1 Azabicyclic compounds are central nervous system active agents |
| 02/25/2004 | EP1391460A1 Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 02/25/2004 | EP1390422A1 Thiophenes and polymers derived therefrom |
| 02/25/2004 | EP1390022A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno 2,3-d]pyrimidine for the treatment of pain |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1139594C 3,9-bis (dicyanomethylene)-2,4,8,10-tetrathioheterospiro [5,5] undecane and its preparation method |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696182 Organic electroluminescent device comprising dipyridylthiophene derivative |
| 02/24/2004 | CA2013519C Sulfonyl derivatives of thieno-triazolo-diazepines, a preparation process of the same and therapeutic compositions containing them |
| 02/24/2004 | CA2013518C Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them |
| 02/19/2004 | WO2004015024A1 Photochromic and electrochromic compounds and methods of synthesizing and using same |
| 02/19/2004 | WO2004014921A1 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014895A1 Piperazine substituted aryl benzodiazepines |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014850A2 Substituted aminopyrimidines as neurokinin antagonists |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014384A2 Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014375A2 Fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2003057149B1 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones |
| 02/19/2004 | US20040034076 Such as methyl-3-azido-2-((4,6-dimethoxy-2-pyrimidinyl)oxy) 3,3-diphenylpropionate; for treatment of high blood pressure |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034054 Fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | US20040034040 E.g., 5-(4-(3-chloro-4-methoxybenzylamino)-5,6,7,8-tetra-hydro-1-benzothieno(2,3 -d) pyrimidin-2-yl)valeric acid to treat high pullmonary pressure; hypotensive agents; liver, cardiovascular, kidney and sexual disorders; antiallergens |
| 02/19/2004 | US20040034039 An oval tablet comprising a drug, e.g., an antigonadotrophin, a slightly water-soluble, water-repellant, cellulose-type disintegrant, a binder and a stearate lubricant; improved granulability; storage stability; drug delivery; oval tablets |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034005 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/19/2004 | CA2495518A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2494920A1 Photochromic and electrochromic compounds and methods of synthesizing and using same |
| 02/18/2004 | EP1181295B1 Tricyclic benzoylcyclohexanedione derivatives |
| 02/18/2004 | EP0759922B1 New antagonist compounds |
| 02/18/2004 | CN1138780C Thienopyrimidines |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693115 2-acetoxy-5-(alpha-cyclopropylcarbonyl-o-fluorobenzyl)--4,5,6,7 -tetrahydrothieno(3,2-c)-pyridine, particularly the hydrochloride and the maleate |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003037903A8 Olanzapine dihydrate-ii a process for its preparation and use thereof |
| 02/12/2004 | WO2003035652A8 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES |
| 02/12/2004 | WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 02/12/2004 | US20040030150 Method for hydrogenating c-c double bonds |
| 02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 02/12/2004 | US20040030078 Novel photochromic polymers and methods of synthesizing same |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/11/2004 | EP1387827A2 Synthesis of cyclopentadiene derivatives |
| 02/11/2004 | EP1387687A2 Novel use |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/10/2004 | US6689885 Method for producing thienopyrimidines |
| 02/10/2004 | US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/10/2004 | US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics |
| 02/10/2004 | CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/05/2004 | WO2004011557A1 Functional fluorescent dyes |
| 02/05/2004 | WO2004011556A1 Site-specific labelling of proteins using cyanine dye reporters |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024210 New compounds |
| 02/05/2004 | US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors |
| 02/05/2004 | US20040024009 Dihydropyrazolo[3,4-d]thieno-[2,3-B]pyridinone inhibitors of B7-1 |
| 02/05/2004 | US20040023987 Sustained release compositions |